ArticleFrontiers in pharmacology2025
Harnessing dual variational autoencoders to decode microbe roles in diseases for traditional medicine discovery.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predicting Potential Microbe-Disease Associations Based on Heterogeneous Graph Random Attention Neural Network and Neural Collaborative Filtering.Interdisciplinary sciences, computational life sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional medicine encompasses a rich trove of knowledge and practices for disease prevention, diagnosis, and treatment. However, it faces challenges such as poorly defined compositions of preparations and limited high-quality efficacy data. The development of artificial intelligence presents new opportunities for traditional medicine research and applications, especially in predicting MDAs (MDAs), which is of great significance for understanding disease mechanisms and developing new treatments. This study proposes a MDAs prediction method based on double variational autoencoders (DVAMDA). This method innovatively integrates double variational autoencoders and multi-information fusion techniques. Firstly, the graph SAGE encoder is utilized to preliminarily extract the local and global structural information of nodes. Subsequently, the double variational autoencoders are employed to separately extract the latent probability distribution information of the initial input data and the graph-specific property information from the output of the graph SAGE encoder. Then, these different sources of information are fused to provide rich and powerful feature support for subsequent prediction tasks. Finally, the Hadamard product operation and a deep neural network are used to predict MDAs. Experimental results on the HMDAD and Disbiome datasets show that the DVAMDA model performs outstandingly in multiple evaluation metrics. The findings of this research contribute to a deeper understanding of microbe-disease relationships and provide strong support for drug development in traditional medicine based on MDAs. The relevant data and code are publicly accessible at: https://github.com/yxsun25/DVAMDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.